<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1436</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2024-32-1-83-88</article-id><article-categories><subj-group subj-group-type="heading"><subject>Неопределен</subject></subj-group></article-categories><title-group><article-title>The actual issues of improvement of organization of screening of skin neoplasms in out-patient conditions</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gusarov</surname><given-names>Mikhail Vyacheslavovich</given-names></name><email>not@provid.ed</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tayts</surname><given-names>Boris Mikhailovich</given-names></name><email>boris.tayts@szgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barinova</surname><given-names>Anna Nikolaevna</given-names></name><email>not@provid.ed</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">The Federal State Budget Educational Institution of Higher Education “The I. I. Mechnikov North-Western State medical University of Minzdrav of Russia”, 191015, St. Petersburg, Russia</aff><pub-date date-type="epub" iso-8601-date="2024-02-11" publication-format="electronic"><day>11</day><month>02</month><year>2024</year></pub-date><volume>32</volume><issue>1</issue><history><pub-date date-type="received" iso-8601-date="2025-04-19"><day>19</day><month>04</month><year>2025</year></pub-date><pub-date date-type="accepted" iso-8601-date="2025-04-19"><day>19</day><month>04</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 2025,</copyright-statement><copyright-year>2025</copyright-year></permissions><abstract>&lt;p&gt;The skin malignant neoplasms constitute one of significant problems of public health. The increasing of morbidity and mortality of melanoma and other types of skin cancers is registered. The early detection of disease assures mortality decreasing and increases survival of patients.&lt;br /&gt;The purpose of the study is to develop optimal model of organizational and preventive measures of early diagnostic of malignant skin tumors. The comprehensive study was carried out, which included assessment of survey of patients using questionnaire Melanoma Diagnosis Day. Also it included identification of level of awareness of physicians about screening, medical records of patients during COVID-19 pandemic, risk groups identification and effectiveness of selecting patient for screening. The total number of observations is 21 581. The selective and continuous observation method was applied and parametric and non-parametric methods as well. The study determined that during COVID-19 pandemic in 2020, there was significant reliable uncompensated decrease in the number of patients with diagnosis of ICD D23, L82, C44 and decrease in the number of detected diseases. The melanoma, basalioma and other skin malignant neoplasms are reliably more common in patients of medium-high risk group, aged 60 years and older and in persons sunburned at the age of 18 years. The assignation of separate specialist to diagnose skin neoplasms allows statistically reliably increase rate of morphological confirmation of malignant neoplasms as compared to common reception by dermatologist. The sociological survey of physicians revealed statistically reliable difference in knowledge between dermatovenereologists, oncologists and physicians of other specialties concerning screening issues. The results of the study permitted to develop complex of organizational measures to improve screening. The model of organizational and preventive measures for early diagnostic of skin malignant tumors in outpatient conditions was proposed.&lt;/p&gt;</abstract><kwd-group xml:lang="en"><kwd>malignant neoplasm</kwd><kwd>skin</kwd><kwd>melanoma</kwd><kwd>organization of screening</kwd><kwd>model</kwd><kwd>organizational and preventive measures</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>злокачественные новообразования кожи</kwd><kwd>меланома</kwd><kwd>организация скрининга</kwd><kwd>модель организационных и профилактических мероприятий</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>American Cancer Society. Cancer Facts &amp; Figures 2021. Atlanta, Ga: American Cancer Society; 2021. 21 p.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kaprin A. D., Starinsky V. V., Shakhzadova A. O. (eds). Malignant neoplasms in Russia in 2019 (morbidity and mortality). Moscow: National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 2020. P. 4–11 (in Russian).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Heistein J., Acharya U., Mukkamalla S. Malignant Melanoma. Treasure Island: StatPearls Publishing; 2022.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Schadendorf D., van Akkooi A. C. J., Berking C., Griewank K. G., Gutzmer R., Hauschild A., Stang A., Roesch A., Ugurel S. Melanoma. Lancet. 2018;392(15):971–84. doi: 10.1016/S0140-6736(18)31559-9</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Screening programmes: a short guide. Increase eff ectiveness, maximize benefits and minimize harm. Copenhagen: WHO Regional Office for Europe; 2020.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Neprash H., Chernew M. Physician Practice Interruptions in the Treatment of Medicare Patients During the COVID-19 Pandemic. JAMA. 2021;326(13):1325–8.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Barinova A. N., Gusarov M. V., Tayts B. M., Plavinskĳ S. L. Necessity of organizational model improvement of skin neoplasms screening within covid-19 pandemic restrictions. Profilakticheskaya i klinicheskaya medicina. 2021;80(3):21–7 (in Russian).</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Litchman G. H., Rigel D. S. The immediate impact of COVID-19 on US dermatology practices. J. Am. Acad. Dermatol. 2020;83(2):685–6.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Garbe C., Keim U., Eigentler T. K. Time trends in incidence and mortality of cutaneous melanoma in Germany. J. Eur. Acad. Dermatol. Venereol. 2019;33:1272–80.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Demidov L., Samoylenko I., Vandet N. Screening for Melanoma and Other Skin Cancer Shows a Higher Early Melanoma Incidence: Social Educational Program “Life Fear-Free”. Dermatopathology (Basel). 2021;8(1):54–68.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Davies J. R. Development and validation of a melanoma risk score based on pooled data from 16 case-control studies. Cancer Epidemiol. Biomarkers Prev. 2015;24(5):817—24.</mixed-citation></ref></ref-list></back></article>
